Members of the Ets famnily of winged helix-loop-helix transcription factors play important roles in the development and function of multiple mammalian cell lineages.
Introduction
The Ets transcription factors are a large family of winged helix-loop-helix DNA binding proteins that recognize purine-rich motifs centered around the core sequence, GGA A/T (1) (2) (3) (4) (5) (6) (7) (8) . Ets proteins are expressed in a wide variety of species including nematodes, sea urchins, flies, frogs, birds, mice, and humans. Invertebrate Ets proteins are both positive and negative regulators of development, as in vulval cell-fate determination in Caenorhabditis elegans, and steroid-induced metamorphosis, photoreceptor ontogeny, and oogenesis in Drosophila (9) (10) (11) (12) (13) (14) (15) (16) . At least 17 different mammalian Ets proteins have been described to date. Many of these proteins are expressed in a cell lineage-restricted pattern, and some, but not all, display oncogenic potential (7) . Recent gene targeting studies (17) (18) (19) have demonstrated important roles for two Ets proteins, Ets-1 and PU. 1, in regulating the development and function of specific hematopoietic cell lineages in the mouse.
Elf-I is an Ets-related transcription factor that was originally cloned from a human T cell library by hybridization with a probe encoding the DNA binding domain (Ets domain) of the human Ets-1 cDNA (20) . Subsequently, func-tionally important Elf-i binding sites have identified in the transcriptional regulatory elements of multiple genes involved in T cell, B cell, and macrophage development and activation; these genes include those for interleukin-3 (IL-3) (21), IL-2 receptor alpha subunit (IL-2Ra) (22) , granulocyte macrophage-colony stimulating factor (GM-CSF) (23) , CD2 (24) , CD4 (25) , immunoglobulin heavy chain (IgH), terminal deoxynucleoidyltransferase (TdT) (26) , c-Fes (27) , and the HIV-2 LTR (28) (29) (30) . In accord with these findings, Elf-i is known to be expressed at high levels in both normal T cells and immortalized T cell lines. However, its pattern of expression during mammalian development and its spectrum of expression in adult mammalian tissues and cell lineages have remained unknown. Such information might be expected to provide important clues as to the function of the protein, and should also be useful in interpreting the phenotype of mice with targeted mutations of the Elf-i gene. To address these questions directly, we have analyzed the pattern of expression of Elf-i during murine embryogenesis, in adult murine tissues, in lymphoid subsets, and in immortalized human and murine cell lines.
Materials and Methods
In Situ Hybridization In situ hybridization was performed as described by Kuratani and co-workers (31) and by Parmacek and co-workers (32) . A cDNA fragment encompassing bp 19-850 of the murine Elf-i cDNA (33) was subcloned into EcoRI-digested pGEM7Z (Promega, Madison, WI). The resulting plasmid was transcribed in vitro using T7 or SP6 polymerase in the presence of "S-labeled UTP to generate anti-sense and sense cRNA probes, respectively. Following hybridization with either sense (control) or anti-sense Elf-i cRNA probes, sections were processed for emulsion autoradiography, were post-stained with Hoechst 33258, and visualized by epiflourescence and dark-field microscopy on a Zeiss Axiophot microscope.
Western Blot Analysis Tissues (from 7-week-old CDi mice) and cell lines were lysed in NETN (20 mM Tris [pH 8.0], 100 mM NaCl, 1 mM EDTA, and 0.5% NP-40), and the protein concentrations of the resulting lysates were determined using a commercially available kit (Pierce, Rockford, IL). Then 100 .g of cell extract was denatured by boiling in SDS-PAGE loading buffer (50 mM Tris (pH 6.8), 30% glycerol, 0.4% SDS, 0.1 % bromophenol blue, and 10% f3-mercaptoethanol) and was resolved by electrophoresis in 8% SDS-containing polyacrylamide gels. Proteins were transferred to nitrocellulose membranes (34) and the resulting immunoblots were probed with a 1:500 dilution of the a-Elf-i monoclonal antibody (mAb) 5A3 in conjunction with a 1:3000 dilution of a commercially available horseradish peroxidase-coupled goat antibody to mouse immunoglobulin (Ig) (GIBCO BRL, Grand Island, NY). Immunoblots were developed using a commercially available kit (Amersham, Arlington Heights, IL) as described previously (34) . The 5A3 a-Elf-i mAb was produced by immunization of BALB/c mice with bacterial Elf-i protein. It recognizes a Cterminal epitope of Elf-i and does not cross-react with other Ets proteins (B. Cobb and J. Leiden, unpublished data).
Immunohistochemical Analysis Paraffin-embedded sections from 7-week-old CD 1 mice were baked at 600C for 1 hr, cleared in xylene, and hydrated in descending alcohol concentrations with distilled water. The hydrated tissue sections were placed in 0.01 M citrate buffer (pH = 7.0). Endogenous peroxidase activity was blocked by treating sections with 3% hydrogen peroxide in methanol for 20 mm. Tissue sections were then incubated overnight at 40C with an Elf-i-specific polyclonal antiserum (35) . Immunohistochemical staining was performed on a Ventura Gen System (Ventura Medical Systems), and sections were counterstained with hematoxylin.
Purification of Lymphocyte Subsets
To purify splenic B cells, ammonium chloridelysed splenocytes from adult CD 1 mice were subjected to combined anti-Thy-i and anti-CD8 plus complement depletion. Cells were then stained with fluorescent (FITC)-labeled R40-97 (anti1gM) and phycoerythrin (PE) -labeled RA3-6B2 (anti-B220) (Pharmingen, San Diego, CA). IgM./B220. positive cells were sorted on a FAC Star PLUS (Becton-Dickinson, Thousand Oaks, CA). Splenic T cells from adult CD 1 mice were purified from red cell-depleted spleens using a mouse T cell enrichment column according to the manufacturer's instructions (R&D Systems, Minneapolis, MN). The purity of the final T In the ED20 embryo, the Elf-1 riboprobe hybridized specifically to the thymus (T), mouth, lung (L), bladder (Bl), and the epithelial and mucosal layers of the esophagus (Eo), stomach (St) (see also Fig. 2F ), small intestine (Si), and colon (Co). Lower-intensity hybridization was also observed in the skin epithelia (Se) and in the kidney (K). Elf-I expression was not observed in the developing heart (He). The liver (Li), thyroid (Th), and adrenal gland (Ad) hybridized to both the anti-sense and sense probes. Note that the intense fluorescence due to erythrocytes (Er) is the result of the refractile property of these cells under dark-field microscopy and does not represent Elf-l-specific gene expression. cell populations was determined by flow cytometry using FITC-labeled 145-2C II (anti-CD3). All preparations contained at least 98% CD3 T cells. Single positive (SP) CD4+ and CD8+ cells were obtained from the spleens of adult CD1 mice as follows: Red cell-depleted splenocytes were stained with PE-labeled RM-4-5 (anti-CD4) or FITC-labeled 53-6.7 9 (anti-CD8) (Pharmingen, San Diego, CA) and sorted on a FACStar PLUS (Becton-Dickinson). Double positive (DP) adult CDL thymocytes were obtained by FACSsorting following staining with PE-labeled RM-4-5 (anti-CD4) and FITC-labeled 53-6.7 9 (anti-CD8). Double negative (DN) (CD4-/CD8 ) thymocytes were obtained directly from the thymus of a RAG2 mouse, as RAG2 mice display a block in thymocyte development at the DN stage. Finally, 2 X 106 cells from each population were denatured in SDS loading buffer, resolved by electrophoresis in 8% SDS-containing polyacrylamide gels, and subjected to immunoblot analysis as described above.
Results

Expression of Elf-i during Murine Embryogenesis
To determine the temporal and spatial patterns of expression of Elf-I during murine development, in situ hybridization experiments were performed using an Elf-I -specific riboprobe. This probe contains nucleotides of the murine Elf-i cDNA, including 301 nucleotides of 5' untranslated sequence and 530 nucleotides from the N-terminal region of the Elf-I protein (33 (Fig. IC, D) . Elf-I expression was also detected in the developing spleen (data not shown). In contrast, Elf-I expression was not detected in developing skeletal muscle, smooth muscle, heart, or brain (Fig. 1B, D) . We could not accurately assess the levels of Elf-1 expression in the developing liver, thyroid, or adrenals because the sense and antisense probes hybridized equally well to these organs. Taken together, these results demonstrated that during murine embryonic development, Elf-I is preferentially expressed in the lymphoid organs (thymus and spleen) and in a wide variety of epithelial cells, including those lining the gastrointestinal, urogential, and respiratory tracts, the CNS, and the skin.
Expression of Elf-I in Adult Mouse Tissues
To determine the tissue distribution of Elf-I protein expression in the adult mouse, cell extracts obtained from adult murine tissues were subjected to Western blot analysis using a monoclo-nal antibody that specifically recognizes a nonconserved C-terminal epitope of Elf-I (a-Elf-I mAb). As shown in Figure 3 , Elf-I (which migrates as a 97-kD doublet by SDS-PAGE) is expressed most abundantly in adult hematopoietic tissues, including thymus, spleen, and bone marrow. Elf-I is expressed at moderate levels in the adult testis, liver, kidney, small intestine, and bladder and at very low levels in the adult heart and lung. Low levels of Elf-I protein were also detected in the adult ovary and oviducts (data not shown). Elf-I protein was undetectable in adult skeletal muscle and brain. Identical patterns of Elf-I expression were observed in Western blotting experiments using a second mAb that recognizes an N-terminal epitope of the Elf-I protein (data not shown).
To further demonstrate the expression of the Elf-I protein in adult mouse tissues, sections of adult mouse gut and skin were subjected to immunohistochemical analysis using a polyclonal antibody to Elf-1 (3 5). Elf-I protein was detected at high levels in epithelial cell of the gut and skin (Fig. 4A, B) . Immunohistochemical staining of Elf-I protein was also observed in embryonic mouse thymus, gut, and skin (data not shown).
Expression of Elf-i in Lymphocyte Subsets
To further explore the patterns of Elf-i expression during T cell development, we performed Western blot analyses on extracts from purified T cell subsets, including immature CD4 CD8 (DN) thymocytes, more mature CD4+CD8+ (DP) thymocytes, and mature CD4+CD8 or CD8+CD4 (SP) thymocytes and resting splenic T cells (Fig. 5) . Equivalent levels of Elf-I expression were detected in each of the T cell subsets. In addition, Elf-I was found to be expressed at a similar level in purified mature IgM+B220+ B cells (Fig. 5) . Thus, Elf-I is expressed in both normal murine B and T cells, and its levels of expression are relatively constant throughout thymocyte ontogeny.
Expression of the Elf-i Protein in Human and
Murine Cell Lines To more precisely determine the pattern of Elf-I expression in specific cell lineages, we assayed Elf-i expression by Western blot analysis in a large number of immortalized murine and human cell lines (Fig. 6) . As expected, Elf-i was expressed at high levels in all of the T and B cell lines tested including the Jurkat T cell lymphoma (Fig. 6, lane 1) , the B and T lymphoblast hybrid CEMT.1 (Fig. 6, lane 3) , the IL-2-dependent cytotoxic T cell line CTLL-2 (Fig. 6, lane 14) , the T cell lymphoma EL-4 (Fig. 6, lane 13) , the B cell lymphomas clone 12 and Bcl-l (Fig. 6, lanes 2  and 4) , and the plasmacytoma P815 (Fig. 6, lane  15) . In addition, high-level Elf-I expression was observed in other hematopoietic cell lineages including the monocyte cell lines U937 (Fig. 6, lane  5) and (Fig. 6, lane 6) , and the erythroleukemia cell line K562 (Fig. 6, lane 7) . Somewhat surprisingly, Elf-I was also expressed at high levels in two cell lines derived from prostatic adenocarcinomas, PC-3 and LNCaP (Fig. 6,  lanes 11, 12) . Much lower but detectable levels of Elf-i protein were found in other cell lines including the SAOS and U20S osteosarcomas (Fig. 6, lanes 8, 9) , HeLa cells (Fig. 6, lane 10) , the fibroblast cell lines NIH-3T3 (Fig. 6 , lane 16) and STO (Fig. 6, lane 18) , the skeletal muscle cell line C2C12 (Fig. 6, lane 17) , and the murine embryonic stem cell line CCE (Fig. 6, lane 19) . Taken together, these data were consistent with the Western blot and in situ hybridization analyses of normal mouse tissues demonstrating that Elf-I is expressed at low levels in many different cell lineages and at high levels in hematopoietic cells (B cells, T cells, and macrophages) as well as in cells of prostatic origin.
Discussion
In the studies described in this report we have characterized the spatial and temporal patterns of expression of the Ets-related transcription factor Elf-i. Consistent with previous studies, our data demonstrate high-level Elf-i expression in thymocytes and T cells. Moreover, levels of Elf-I expression were shown to be relatively constant throughout thymocyte differentiation. Highlevel Elf-I expression was also demonstrated in mature B cells. Somewhat surprisingly, however, we found that Elf-I expression is not limited to the lymphoid cell lineages and that Elf-I is in fact expressed in cell lineages that are derived from all three embryonic germ layers. High-level Elf-I expression was detected in macrophages and in multiple developing epithelial cells, including those lining the respiratory, gastrointestinal, and urogenital tracts as well as those in the skin and in two different prostatic adenocarcinoma cell lines. Moreover, low-level Elf-I expression was seen in many immortalized human and murine cell lines. These data have potential implications for understanding the function of Elf-I in both embryonic and adult tissues.
Recently, four mammalian Elf-I related genes, Elf-2 (36), NERF (37), MEF (38) , and Elf-3/ESE-1 /ESX/JEN, have been isolated. All four Elf-l-related proteins share highly related DNA binding domains and DNA binding properties. The initial descriptions of these related tran- (40) . Taken together with our description of Elf-I expression in multiple epithelial cell lineages, these results suggest an important role for the Elf subfamily of transcription factors in the regulation of epithelialspecific gene expression. We have reported previously that the activity of Elf-I in T cells is regulated by interactions with the retinoblastoma protein and that these interactions in turn are regulated in a cell cycledependent fashion. Thus, it has been suggested that Elf-I may serve as an important regulator of cell cycle-specific gene expression. In this regard, it is of interest that the terminal differentiation of T cells, B cells, macrophages, and epithelial cells (each of which expresses high levels of Elf-1i) are all tightly regulated in relation to cell proliferation. Thus, for example, proliferating undifferentiated epithelial cells in the crypts of the gut or the basal layers of the skin withdraw from the cell cycle as they differentiate and migrate to form the surface epithelium (44, 45) . Conversely, resting T and B cells are both proliferatively and transcriptionally quiescent until activated by an appropriate antigenic peptide, at which time they simultaneously proliferate and coordinately express a set of activation-specific genes. Thus, it is tempting to speculate that Elf-I may function in some way to coordinate differentiation-specific gene expression and cell-cycle progression in these diverse cell lineages. It In an attempt to circumvent this problem, gene targeting has been used to more precisely characterize distinct roles for specific Ets proteins in mammalian hematopoiesis. We have recently produced a targeted mutation of the murine Elf-I gene and transmitted this mutation through the germ line. Our findings concerning the patterns of Elf-I expression in normal mice should facilitate the interpretation of the phenotypes of these Elf-l-deficient animals.
